Figures below are as of 21 Jul 2026. GMP is an unofficial, unregulated indicator of grey-market demand and is not investment advice.
| Grey Market Premium (GMP) | ₹1 |
| Estimated listing gain | +0.9% |
| Estimated listing price | ₹109 |
| Issue price | ₹108 |
| Issue size | ₹31.26 Cr |
| Subscription | 22.33x |
| Open date | 06 Feb 2026 |
| Close date | 10 Feb 2026 |
| Listing date | 13 Feb 2026 |
| Listing at | NSE SME |
| IPO type | SME |
| Registrar | Bigshare Services Pvt.Ltd. |
As of 21 Jul 2026, the grey market premium (GMP) for the Biopol Chemicals Ltd. IPO is ₹1, implying an estimated listing gain of about +0.9% and an estimated listing price near ₹109. GMP is unofficial and unregulated — it indicates grey-market sentiment, not a guaranteed listing price.
The Biopol Chemicals Ltd. IPO is open for subscription from 06 Feb 2026 to 10 Feb 2026. It is expected to list on 13 Feb 2026.
The Biopol Chemicals Ltd. IPO is priced at ₹108 per share, with a total issue size of ₹31.26 Cr.
As of 21 Jul 2026, the Biopol Chemicals Ltd. IPO is subscribed 22.33x.